haloperidol has been researched along with 4-carboxy-3-hydroxyphenylglycine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lorenc-Koci, E; Pilc, A; Wardas, J; Wolfarth, S | 1 |
1 other study(ies) available for haloperidol and 4-carboxy-3-hydroxyphenylglycine
Article | Year |
---|---|
(S)-4C3HPG, a mixed group I mGlu receptor antagonist and a group II agonist, administered intrastriatally, counteracts parkinsonian-like muscle rigidity in rats.
Topics: Animals; Anti-Dyskinesia Agents; Corpus Striatum; Disease Models, Animal; Electromyography; Glycine; Haloperidol; Male; Microinjections; Muscle Rigidity; Neuroprotective Agents; Parkinsonian Disorders; Rats; Rats, Wistar; Receptors, Metabotropic Glutamate; Tarsus, Animal | 2001 |